Publicaciones en colaboración con investigadores/as de Hospital Ramón y Cajal (34)

2024

  1. Emotional intelligence and neurocognition profiles in first-episode psychosis: A two-year follow-up study

    European Neuropsychopharmacology, Vol. 85, pp. 66-77

  2. Inflammatory blood cells and ratios at remission for psychosis relapse prediction: A three-year follow-up of a cohort of first episodes of schizophrenia

    Schizophrenia Research, Vol. 267, pp. 24-31

2023

  1. Relapse, cognitive reserve, and their relationship with cognition in first episode schizophrenia: a 3-year follow-up study

    European Neuropsychopharmacology, Vol. 67, pp. 53-65

  2. The polygenic basis of relapse after a first episode of schizophrenia

    European Neuropsychopharmacology, Vol. 75, pp. 80-92

2022

  1. FPR2 DNA Aptamers for Targeted Therapy of Wound Repair

    Journal of Investigative Dermatology, Vol. 142, Núm. 8, pp. 2238-2248.e8

  2. First-in-human phase I clinical trial of a TLR4-binding DNA aptamer, ApTOLL: Safety and pharmacokinetics in healthy volunteers

    Molecular Therapy - Nucleic Acids, Vol. 28, pp. 124-135

  3. Neuroprotective and Anti-Inflammatory Effects of Linoleic Acid in Models of Parkinson’s Disease: The Implication of Lipid Droplets and Lipophagy

    Cells, Vol. 11, Núm. 15

  4. The network structure of cognitive deficits in first episode psychosis patients

    Schizophrenia Research, Vol. 244, pp. 46-54

2021

  1. How does neighbourhood socio-economic status affect the interrelationships between functioning dimensions in first episode of psychosis? A network analysis approach

    Health and Place, Vol. 69

  2. Impact of previous tobacco use with or without cannabis on first psychotic experiences in patients with first-episode psychosis

    Schizophrenia Research, Vol. 236, pp. 19-28

  3. The interplay between functioning problems and symptoms in first episode of psychosis: An approach from network analysis

    Journal of Psychiatric Research, Vol. 136, pp. 265-273

  4. The usefulness of Olanzapine plasma concentrations in monitoring treatment efficacy and metabolic disturbances in first-episode psychosis

    Psychopharmacology, Vol. 238, Núm. 3, pp. 665-676

2020

  1. Birth weight and antipsychotic induced weight gain: A prenatal programming approach in the PEPs study

    Schizophrenia Research, Vol. 218, pp. 292-294

2019

  1. Gene-environment interaction between an endocannabinoid system genetic polymorphism and cannabis use in first episode of psychosis

    European Neuropsychopharmacology, Vol. 29, Núm. 6, pp. 786-794

2018

  1. Novel DNA Aptamers Against CCL21 Protein: Characterization and Biomedical Applications for Targeted Drug Delivery to T Cell-Rich Zones

    Nucleic Acid Therapeutics, Vol. 28, Núm. 4, pp. 242-251

  2. TLR4-Binding DNA Aptamers Show a Protective Effect against Acute Stroke in Animal Models

    Molecular Therapy, Vol. 26, Núm. 8, pp. 2047-2059

  3. Use of complementary tests in emergencies and their relation with patient safety incidents

    Journal of Healthcare Quality Research, Vol. 33, Núm. 2, pp. 75-81

2016

  1. Characterization of MNK1b DNA Aptamers that inhibit proliferation in MDA-MB231 breast cancer cells

    Molecular Therapy - Nucleic Acids, Vol. 5, pp. e275

2014

  1. Predictive factors of severe multilobar pneumonia and shock in patients with influenza

    Emergency Medicine Journal, Vol. 31, Núm. 4, pp. 301-307

2013

  1. DNA Aptamers Selectively Target Leishmania infantum H2A Protein

    PLoS ONE, Vol. 8, Núm. 10